HOME >> BIOLOGY >> NEWS
Most clones doomed from the start, according to Temple University embryologist

Until scientists can improve the early development of cloned embryos, cloning will remain marginally successful, according to research presented today at the American Association for the Advancement of Science (AAAS). Currently, only 1-5 percent of cloned embryos succeed, and many that do succeed are unhealthy.

Keith Latham, Ph.D., Associate Professor of Biochemistry at Temple University School of Medicine, presented the research during the symposium, "Cloning Controversies: Ethics, Science and Society." Latham's presentation, "Somatic Cell-Like Features of Cloned Embryos," highlighted the differences that persist between a normal embryo and a cloned embryo and stand in the way of cloning success.

Contributing to the poor success is the inefficiency and slow rate of reprogramming. Reprogramming is the process whereby cloned embryo genes are turned off and normal embryo genes are turned on, allowing a cloned embryo to develop normally. For some reason, most cloned embryos are unable to make this transformation. Consequently, cloned embryos develop and behave as a hybrid somewhere between an embryo and the adult organism from which it has been cloned.

"Until we learn how to improve the reprogramming of cloned embryos and how to help them transition into a normal, healthy embryo, cloning will remain marginally successful," said Latham.

Latham's research portfolio is focused on reproduction and development at the molecular level. He is currently running four major research projects, all funded by the National Institutes of Health.


'"/>

Contact: Eryn Jelesiewicz
eryn.jelesiewicz@temple.edu
215-707-0730
Temple University
16-Feb-2004


Page: 1

Related biology news :

1. Advance warning of storms and cyclones with new technique
2. Texas A&M clones first cat
3. New study shows normal-looking clones may be abnormal
4. The silence of the clones: new link between DNA replication and silent chromosome architecture
5. Dyslexics not doomed to life of reading difficulties
6. Portrait of a doomed Sea
7. The future of HIV therapeutics is brightening, according to Gladstone Institutes Director
8. Mitochondria in spinal cords is ALS target according to UCSD medical researchers
9. Espionage may have driven the evolution of bee language according to UCSD-led study in Brazil
10. Chicken litter harbors agents that generate antibiotic multi-resistance, according to UGA study
11. Governing commons still a struggle, but fight not without hope, according to new report

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/12/2018)... Calif. (PRWEB) , ... September 10, 2018 , ... ... a paper detailing the performance of its new Multiplexed Ion Beam Imaging (MIBITM) ... September 6 issue. This study will also be shared during a webinar presented ...
(Date:9/7/2018)... ... September 05, 2018 , ... ... mAb manufacturing facility late last year, IPS-Integrated Project Services, LLC and G-CON Manufacturing ... autologous cell therapies. The iCON solution provides a pre-fabricated modular cleanroom infrastructure for ...
(Date:8/31/2018)... , ... August 30, 2018 , ... ... offering a complimentary cryogenic freezer program for new clients. The freezers are very ... regenerative biologics from R3 Stem Cell consist of amniotic and umbilical cord tissue. ...
Breaking Biology News(10 mins):
(Date:8/31/2018)... ... August 30, 2018 , ... Small, wireless and networked describes more than the ... connected, too. Draper’s latest system is tiny in size, but is poised to make ... in the new implant design is the growing awareness that disease often involves complex ...
(Date:8/29/2018)... Calif. (PRWEB) , ... August 28, 2018 , ... ... scientists from around the world, is proud to announce the launch of a new ... offers for a chance to win one of LabRoots most popular shirts. , Throughout ...
(Date:8/23/2018)... ... August 23, 2018 , ... Visikol began ... Dr. Thomas Villani. Through support from advisors, mentors, the Rutgers Technology Transfer team and ... Visikol’s path from an idea to a successful biotech company has been a circuitous ...
(Date:8/17/2018)... (PRWEB) , ... August 16, 2018 , ... ... testing, announced their results from the AmbryShare project were published today in JAMA ... in the largest exome study ever conducted. , Every year hereditary breast cancer ...
Breaking Biology Technology:
Cached News: